Solvay, a leading global supplier of specialty polymers, has introduced a new medical grade of Ixef PARA for single-use surgical instruments and biopharma processing components with rotating parts, as per the company's press release.
Ixef GS-5022 brings increased lubrication to the well-known combination of mechanical properties and ultra-smooth finish associated with Ixef GS-1022, already widely used in healthcare applications.
“Ixef GS-5022 has been developed to meet customer needs for single-use instruments with moving parts that require smooth, minimum force movement and reduced noise,” said Guruprasad Sivakumar, Head of Healthcare Marketing at Solvay. “The increased level of lubrication makes Ixef GS-5022 the ideal solution wherever you expect to have high friction in surgical instruments such as stent crimpers or components of single-use instruments functioning at high rotational speeds.”
Ixef= GS-5022 is an ideal solution to replace metal due to its unique combination of tensile and flexural strength with an aesthetic, ultra-smooth finish. It is also compatible with hospital disinfectants and resistant to high energy gamma radiation without significant changes to its original appearance or physical properties. Therefore, parts made from Ixef GS-5022 can be gamma sterilized in bulk leading to reduced costs, enabling the production of affordable disposable surgical instruments or components for biopharma processing.
As MRC reported before, earlier this month, Solvay partnered with Mitsubishi Chemical Advanced Materials to recycle end-of-life medical components. New collaboration will help customers reach sustainability goals for high-performance Udel PSU polymers in demanding applications.
We remind that Belgian chemicals group Solvay has suspended operations and new investments in Russia after the invasion of Ukraine. The suspension is temporary and will be reviewed in due course, a spokesperson said in early March, 2022, adding that the company had put a task force in place to manage the impact of the measures.
We also remind that in August, 2020, through the acquisition of the Solvay polyamide (PA) business, BASF enhanced its R&D capabilities in Asia Pacific with new technologies, technical expertise, and upgraded material and part testing services. BASF is planning to integrate the R&D centers from Solvay into its R&D existing facilities in Shanghai, China, and Seoul, Korea. The enhanced capabilities will boost BASF’s position as a solution provider to develop advanced material solutions for key industries.
Solvay is a science company whose technologies bring benefits to many aspects of daily life. With more than 24,100 employees in 64 countries, Solvay bonds people, ideas and elements to reinvent progress. The Group seeks to create sustainable shared value for all, notably through its Solvay One Planet plan crafted around three pillars: protecting the climate, preserving resources and fostering better life. The Group’s innovative solutions contribute to safer, cleaner, and more sustainable products found in homes, food and consumer goods, planes, cars, batteries, smart devices, health care applications, water and air purification systems. Founded in 1863, Solvay today ranks among the world’s top three companies for the vast majority of its activities.
MRC